New Strategies for Reducing Cardiovascular Risk in CKD with T2D: Development of Finer Mineralocorticoid Antagonists
Friday, April 1, 2022
Symposium:
6:30 PM – 7:30 PM EDT
5:30 PM – 6:30 PM CDT
4:30 PM – 5:30 PM MDT
3:30 PM – 4:30 PM PDT
This program has not been planned by the ACC planning committee and is a separate CME educational program.
Learning Objectives
After participating in this educational initiative, clinicians should be better able to:
- Review the mechanistic features of novel mineralocorticoid receptor antagonists and differentiate these therapies from earlier mineralocorticoid receptor antagonists
- Evaluate CKD risk in patients with T2D and clinical data with novel mineralocorticoid receptor antagonists to manage the risk of renal deterioration
- Summarize strategies for the management of hyperkalemia in patients receiving mineralocorticoid receptor antagonists
Target Audience
This activity is designed to meet the educational needs of cardiologists and other healthcare practitioners to ensure recognition of CKD risk in patients with T2D and novel strategies for modifying cardiovascular and renal risk in patients with T2D.
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nursing Credit Information
Purpose: Education regarding the management of DKD leads to safe practices, quality care, and continued professional and personal development for cardiovascular and endocrinology-based nurses. CNE Credits: 1.0 ANCC Contact Hour.
Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
Americans With Disabilities Act
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
Release date: April 1, 2022
Expiration date: April 1, 2023
Estimated time to completion: 1 hour
